Does Ezetimibe Cause Liver Problems?
Ezetimibe, a cholesterol-lowering drug often sold as Zetia, can rarely elevate liver enzymes like ALT and AST, signaling potential liver stress. Clinical trials showed these increases in about 0.5-2% of patients, typically mild and reversible upon stopping the drug. Serious liver injury is uncommon, with post-marketing reports of hepatitis or jaundice in isolated cases.[1][2]
How Common Are These Liver Effects?
In monotherapy trials, liver enzyme elevations over three times the upper normal limit occurred in 0.5% of ezetimibe users versus 0% on placebo. When combined with statins like simvastatin, rates rose slightly to around 1-2%, but stayed low overall. Most resolve without intervention, and no widespread pattern of liver failure links directly to ezetimibe alone.[1][3]
Who Gets Liver Issues from Ezetimibe?
Risk appears higher in patients with pre-existing liver conditions, heavy alcohol use, or those on statin combos. Labeling warns against starting in active liver disease and advises monitoring enzymes before and during treatment, especially in the first year. No specific genetic risks are confirmed, but obese or diabetic patients on multiple meds report more enzyme spikes.[2][4]
What Symptoms Should You Watch For?
Signs include fatigue, nausea, dark urine, yellowing skin (jaundice), or upper right abdominal pain. If enzymes exceed three times normal, doctors often pause the drug and retest. Unlike statins, ezetimibe doesn't typically cause muscle-related issues that mimic liver strain.[1][2]
Compared to Statins or Other Cholesterol Drugs?
Statins alone cause enzyme elevations in 0.5-3% of users, similar to ezetimibe-statin combos, but pure ezetimibe monotherapy has a cleaner liver profile. Fibrates or niacin carry higher hepatotoxicity risks. Guidelines still recommend liver tests for all lipid-lowering therapies.[3][5]
What Do Prescribers and Patients Report?
FDA adverse event data logs fewer than 100 serious liver cases tied to ezetimibe since 2002, often confounded by other drugs. Patient forums note transient enzyme bumps that fade, but some switch meds after scares. No black-box liver warning exists.[4]
[1]: Zetia (ezetimibe) Prescribing Information
[2]: Drugs.com - Ezetimibe Side Effects
[3]: NEJM - Ezetimibe and Simvastatin Trial
[4]: FDA FAERS Database Summary
[5]: AHA/ACC Cholesterol Guidelines